InvestorsHub Logo
Followers 9
Posts 610
Boards Moderated 1
Alias Born 08/14/2018

Re: powerbattles post# 367650

Wednesday, 07/28/2021 6:08:59 PM

Wednesday, July 28, 2021 6:08:59 PM

Post# of 402939
Good take on the AVS results from 7/21 from Farrel



New information at AVS :

Brilacidin is effective against all Covid 19 strains tested including the Delta variant.

Brilacidin has a biologic effect against Alpha viruses {encephalitis} and Bunyaviris {Rift Valley Fever}

Brilacidin inhibits pulmonary fibroblasts

Brilacidin's anti-inflammatory effects are confirmed



" Inhibition appears to impact viral integrity in a manner that interferes with entry and/or early
post-entry steps

• Inhibition extends to different strains of SARS-CoV-2 (alpha, beta, gamma and delta strain
assessments are planned)

• Synergistic activity with remdesivir without any apparent increase in toxicity

• Cell type independent inhibition of SARS-CoV-2 (Calu-3, Caco-2, primary lung fibroblasts)"

GLTA Farrel

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News